RxDoctor Payments Data

Peter Lementowski, MD

Adult Reconstructive Orthopaedic Surgery · Valhalla, NYNPI 1942366943

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.5% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Stryker at 37.7% of the total. Reporting peaked in 2019 at $1,654 and has fallen 59.1% since, to $677 in 2025. That places this record below the midpoint for adult reconstructive orthopaedic surgery clinicians in NY, where the typical reported total is $11,547.

$6,845in general payments, 2019–2025

Across 86 payments — averaging $79.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$3K
  • Zimmer Biomet$2K
  • Globus Medical$832
  • Johnson & Johnson$757
  • Smith+Nephew$512
  • Axogen$166
  • plus $386 from 7 others

What the payments were for

  • Travel & lodging$5798%
  • Food & beverage$6,26692%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,845 in reported general payments places this provider in the 35th percentile of 85 adult reconstructive orthopaedic surgery providers in New York.

See all adult reconstructive orthopaedic surgery providers in New York

Medicare billing

Part B allowed, 2024
$113,838
Medicare patients
165
Services billed
455

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Celecoxib19$836
Oxycodone Hcl26$311
Mupirocin48$292
Silver Sulfadiazine11$114

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Valhalla

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →